New agreement: Probi Digestis® in Canada


Probi signs agreement with leading VMS supplier in Canada

Probi has signed a distribution and supply agreement with Jamieson, the leading Canadian producer of vitamins, minerals and supplements (VMS), for the launch of  Probi Digestis® starting in March 2015. Jamieson’s new range of gastrointestinal products, Digestive CareTM, will feature Probi Digestis within the line’s leading product, Daily Relief. Probi has already received its first order valued at MSEK 2.5.

Read the full release here


Notice of Annual General Meeting


Notice of general meeting in Probi AB (publ)

The shareholders of Probi AB (publ) are hereby officially convened to the Annual General Meeting (AGM) which will be held on Thursday 23 April 2015 at 3:00 p.m. at Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden. The intention to participate must have been notified to the company no later than Friday, 17 April 2015 at 4:00 p.m.

Notice of Annual General Meeting

New long-term research collaboration


Probi AB and Wageningen University enter long-term research collaboration 

Probi AB today announces a four-year collaborative research agreement with Professor Michiel Kleerebezem at the Host Microbe Interactomics Group at Wageningen University. The aim of the collaboration is to clarify mechanisms of action for anti-inflammatory activity of probiotic bacteria in order to enable a continued development of novel effective probiotic products.

Read the full release here



Probi Digestis® on new markets in Asia


Probi Digestis® to be launched on new markets in Asia

Probi AB, a leading probiotic research and development company from Sweden and DKSH, the leading Market Expansion Services provider with a focus on Asia, signed an agreement for the launch of Probi Digestis® in Hong Kong and Macau.

Read the full release here

Year-End Report 2014


32% growth and higher operating margin for full-year 2014

Read the full release here

Record order for Probi from US company NBTY


Record order for Probi from US company NBTY

Probi has secured its largest order to date, valued at MSEK 17, from the US company NBTY. Probi is to supply probiotic products that will be included in an already well-established consumer product. In the US, demand for well-documented probiotic products is considerable and the market has been growing by 20% plus over the last couple of years.

Read the full release here

Interim Report January – September 2014


Net sales rose 54% to MSEK 37.1 in the third quarter

Read the full release here

New members to the Scientific Advisory Board


Probi appoints Glenn Gibson, Maria Rescigno and Henrik Vestergaard to Scientific Advisory Board

Probi renews its Scientific Advisory Board to further strengthen its Probiotic business by increasing the understanding of the microbiome and its impact on health.

Read the full release here

Probi Digestis® in Brazil


Probi to launch Probi Digestis® in Brazil 

Probi has signed a distribution agreement with Laboratório Daudt, the oldest Brazilian pharmaceutical company with market presence since 130 years. Following registration, Lab. Daudt plans to launch Probi Digestis® during 2015.

Read the full release here

Gun-Britt Fransson, VP R&D, presents at Financial Hearings


Gun-Britt Fransson, Vice President Research & Development, presents Probi at Financial Hearings

Click here for the presentation